Your browser doesn't support javascript.
loading
Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
Greene, Stephen J; Epstein, Stephen E; Kim, Raymond J; Quyyumi, Arshed A; Cole, Robert T; Anderson, Allen S; Wilcox, Jane E; Skopicki, Hal A; Sikora, Sergey; Verkh, Lev; Tankovich, Nikolai I; Gheorghiade, Mihai; Butler, Javed.
  • Greene SJ; aDivision of Cardiology, Duke University Medical Center, Durham, North Carolina bMedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia cDivision of Cardiology, Emory University, Atlanta, Georgia dDivision of Cardiology, Northwestern University Feinberg School of Medicine eDivision of Cardiology, Stony Brook University, Stony Brook, New York fCardioCell LLC gStemedica Cell Technologies Inc, San Diego, California hCenter for Cardiovascular Innov
J Cardiovasc Med (Hagerstown) ; 18(4): 283-290, 2017 Apr.
Article en En | MEDLINE | ID: mdl-26479144

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Insuficiencia Cardíaca / Cardiomiopatías Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Insuficiencia Cardíaca / Cardiomiopatías Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2017 Tipo del documento: Article